Transthyretin mutations in hyperthyroxinemia and amyloid diseases. - Wikidata - awgldk - TriplyDB

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

http://www.wikidata.org/entity/Q34269382

about

Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE)Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis Inhibitors Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis The proteome response to amyloid protein expression in vivo The sour side of neurodegenerative disorders: the effects of protein glycation.Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis Examples of Fourier transform ion cyclotron resonance mass spectrometry developments: from ion physics to remote access biochemical mass spectrometry.Cerebrospinal fluid proteome profile in multiple sclerosis.Substrate specificity of transthyretin: identification of natural substrates in the nervous system.Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin.Optimal identification of semi-rigid domains in macromolecules from molecular dynamics simulation.A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs Progress in transthyretin fibrillogenesis research strengthens the amyloid hypothesis.Familial conformational diseases and dementias.Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril.Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).Eeyore: a novel mouse model of hereditary deafness.Transthyretin as a thyroid hormone carrier: function revisited.Macular and optic disc edema and retinal vascular leakage in familial amyloid polyneuropathy with a transthyretin Val30Met mutation: a case report Rare thyroid non-neoplastic diseases Anterior segment alterations and comparative aqueous humor proteomics in the buphthalmic rabbit (an American Ophthalmological Society thesis).The effect of tafamidis on the QTc interval in healthy subjects.Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.Does transthyretin function as one of contributors for preeclampsia?Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy.Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants.Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.Peptides Composed of Alternating L- and D-Amino Acids Inhibit Amyloidogenesis in Three Distinct Amyloid Systems Independent of Sequence.Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice.Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis

P2860

Q24311960-1512BD62-D0A6-43E7-BA75-164ABFFB9380 Q24337632-0CF31147-FD4A-48A0-B1A5-87F9D29AFE82 Q24564070-15E2511B-46D2-4BE7-AD32-F509B68031E7 Q24678722-E317DF89-E664-4620-8333-B46DAEED58EF Q27653350-026D37F5-8AC6-4DD1-AFDF-BEC5FC4BBE48 Q28076550-50E67119-AF24-4720-8462-5D16EF8AD67E Q28485287-D42A3DEB-9061-4DB4-ACC6-8FE3533D81B1 Q30386079-31704ECD-0388-41E7-BB08-87694789CAA8 Q30968181-7D5E3896-E6ED-4029-B8B0-150356A520C5 Q33228334-FC98C36C-D77F-43EB-8337-D0A0CA1B5879 Q33299647-CA8B2747-65A7-4405-905A-AA3678BDF88A Q33399237-3F398806-CB90-4350-B9E2-F4F3846DCE38 Q33435248-0CE5A8D7-D457-4455-A95F-C2220FD36F09 Q33586097-D57502E4-C3FC-4B4C-B489-62C77164CB0B Q33692348-01CF8FF9-33CC-4654-B5DF-4DA6017EB7E4 Q33716349-066D1CC7-2CF6-437F-8D8A-271920F5BBC0 Q33952579-0B275417-CB19-4E83-ADF7-4C38AA65365E Q34138249-91F42405-8EB1-427E-A4A6-3011490F1920 Q34416296-E4EF28FC-C987-44A4-99E0-E9A5C9B3E20F Q34429753-A47C78F8-C5EE-4A57-A7B8-4A767B3AEDC8 Q34561167-A2B2F91E-AE1D-4DE4-837F-A52B1E4F46E5 Q34810495-9CD19C90-8BCE-4F39-9E91-5689AFD88308 Q35004931-DB018DD7-4CB0-44C6-8A9E-DA6E19A7C1E8 Q35054949-18F7792D-C69F-4048-8D6D-49141BAD8112 Q35302228-8DD720C7-99B8-4486-A974-593AFE7F6CDA Q35530679-4F368427-23F5-4238-B83A-B876B9B87EC2 Q35676399-E695136E-EA53-4AFF-BD6C-F96896B70968 Q35684808-DAB47651-C741-4F58-BF7B-14A0A512BAD0 Q35747781-032D0FE0-E6CE-4E03-8E38-6107C01B1EE5 Q35820083-8BA8BD7F-AE4D-43E4-8BF8-E595B2214EAE Q35835560-40E18438-01B8-4522-8212-2C41C5A210B4 Q36057473-27FD7604-F270-45B0-AEB6-BC007F31E4AA Q36142761-BCDCD130-820D-4957-AE53-939E6A8FC8B6 Q36615226-8B69689D-F1F0-41C7-91E2-BA54D0416C65 Q36830566-5E5FA782-EB19-48F9-9995-048E6D03524C Q36945618-BB1EDD52-5892-40B4-9870-FE5E0148637D Q37082424-27806274-419F-480A-AADD-CA623BA09650 Q37264601-E39CE71F-8AAC-4A66-B04E-C2C1524017AD Q37335475-84ADF8FE-2A07-413D-AE55-1078D85B3DDE Q37337552-C081B652-23BA-415F-A7C8-CE729A46FAB0

P2860

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

http://www.wikidata.org/entity/Q34269382

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@ast

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@en

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@nl

type

label

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@ast

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@en

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@nl

prefLabel

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@ast

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@en

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@nl

P1433

Q34269382-0216FB22-EEE7-488C-B140-6456E039BCF6

P1476

Q34269382-6ABA7EEC-07D3-403F-9674-0509E1EDC635

P2093

Q34269382-24FD87EA-C1C7-4B64-9339-D5E0D29AAEBA

P2860

Q34269382-0010DD7E-7631-4302-BE15-02EE2A0BF5D4

Q34269382-0765B1BF-6C01-414F-A7D0-3512E42C74C8

Q34269382-0DAF2ED6-5EEF-4623-95CC-B1F72E3586BB

Q34269382-10FAA3F5-4E1C-4B58-8DDC-121C6B888703

Q34269382-1325F8D1-C883-43FA-B495-B8DF609CD51D

Q34269382-1D0C978F-2C2E-4A2F-BAFD-8B495B10B1D1

Q34269382-1E08E8C6-2F07-427D-B116-E36244331B7D

Q34269382-20A0C346-4CB1-4147-88F8-2DFB76D9BDC4

Q34269382-24F469B8-B858-4E69-A484-6028201D68B3

Q34269382-29CDE9B9-31E5-4969-A5AF-6118133261E4

P304

Q34269382-B3C129A7-B4F2-469E-AE8B-66DD622128F9

P31

Q34269382-07A336F5-C6FC-4826-A8A6-57CC94A4D198

P356

Q34269382-C2D0C69E-7B7E-4E2B-9BE5-68858376F4BE

P433

Q34269382-10DFCAF0-9604-450F-A293-1E2BF060C3E6

P478

Q34269382-1A10BE40-656C-4D46-A5FF-940AF1CBB449

P577

Q34269382-A41CA6E7-B31B-4F2F-AEFB-A5DFFC64CE1D

P698

Q34269382-331C5336-AD86-492A-92D0-C38FAF317262

P356

P1433

P1476

Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

@en

P2093

Saraiva MJ

http://www.w3.org/2001/XMLSchema#string

P2860

Fibril in senile systemic amyloidosis is derived from normal transthyretin

A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves

Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award

New transthyretin mutation V28M in a Portuguese kindred with amyloid polyneuropathy.

A new amyloidogenic transthyretin variant (Val122Ala) found in a compound heterozygous patient.

A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient.

A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels.

A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy.

Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate.

A new transthyretin variant (Ser 24) associated with familial amyloid polyneuropathy.

P304

493-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HUMU.1132

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11385707

http://www.w3.org/2001/XMLSchema#string